BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 4260668)

  • 1. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
    Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
    Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
    Constans P; Baron A; Parrot R; Coury C
    Chest; 1972 Jun; 61(6):539-49. PubMed ID: 4624276
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 5. The antituberculosis efficacy of rifampin in 136 patients.
    Davidson PT; Goble M; Lester W
    Chest; 1972 Jun; 61(6):574-8. PubMed ID: 4624279
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampin in initial treatment of advanced pulmonary tuberculosis.
    Corpe RF; Sanchez ES
    Chest; 1972 Jun; 61(6):564-73. PubMed ID: 5032152
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
    Jenne JW; Beggs WH
    Am Rev Respir Dis; 1973 Jun; 107(6):1013-21. PubMed ID: 4197230
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin in the treatment of previously untreated pulmonary tuberculosis.
    Orlowski EH
    Respiration; 1971; 28():Suppl:100-6. PubMed ID: 5004830
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin with ethambutol for drug-resistant tuberculosis.
    Pines A
    Br J Dis Chest; 1971 Jul; 65():178-81. PubMed ID: 4997816
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
    Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
    Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
    [No Abstract]   [Full Text] [Related]  

  • 17. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
    Favez G; Chioléro R; Willa C
    Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
    [No Abstract]   [Full Text] [Related]  

  • 19. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
    Djurisić M; Davidović C; Leposavić M; Jovancvić M; Marković L; Popović S
    Plucne Bolesti Tuberk; 1973; 25(3):251-6. PubMed ID: 4210992
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1971 Sep; 46(9):371-7. PubMed ID: 4330662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.